KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Current Deferred Tax Assets (2016 - 2018)

Idexx Laboratories has reported Current Deferred Tax Assets over the past 10 years, most recently at $30.4 million for Q1 2018.

  • Quarterly results put Current Deferred Tax Assets at $30.4 million for Q1 2018, up 56.75% from a year ago — trailing twelve months through Mar 2018 was $30.4 million (up 56.75% YoY), and the annual figure for FY2017 was $23.5 million, up 30.05%.
  • Current Deferred Tax Assets for Q1 2018 was $30.4 million at Idexx Laboratories, up from $23.5 million in the prior quarter.
  • Over the last five years, Current Deferred Tax Assets for IDXX hit a ceiling of $37.7 million in Q4 2014 and a floor of $16.4 million in Q4 2015.
  • Median Current Deferred Tax Assets over the past 5 years was $23.5 million (2017), compared with a mean of $26.4 million.
  • Biggest five-year swings in Current Deferred Tax Assets: skyrocketed 365.41% in 2014 and later crashed 56.45% in 2015.
  • Idexx Laboratories' Current Deferred Tax Assets stood at $37.7 million in 2014, then crashed by 56.45% to $16.4 million in 2015, then grew by 10.19% to $18.1 million in 2016, then surged by 30.05% to $23.5 million in 2017, then increased by 29.06% to $30.4 million in 2018.
  • The last three reported values for Current Deferred Tax Assets were $30.4 million (Q1 2018), $23.5 million (Q4 2017), and $22.2 million (Q3 2017) per Business Quant data.